Reference:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 -
From GxPlex
| Document information | |
|---|---|
| Reference | EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 |
| Validity area | EU |
| Scope(s) | G |
| Document name | European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 |
| Version / Revision | 2025-06-30 00:00:00 |
| Status | Current |
| Document type | Information from official body |
| Language(s) | EN |
| Description | EMA/216030/2025
EMA staff members who have a Copilot 365 license can utilise Copilot's AI features in different context to support their day-to-day activities based on a risk-based methodology. |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 7 — Unit 7.0.0 |
| Scope | G |
| Document part | - |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Artificial intelligence, EMA, Risk |
Content
EMA/216030/2025
EMA staff members who have a Copilot 365 license can utilise Copilot's AI features in different context to support their day-to-day activities based on a risk-based methodology.
